跳至主要内容
临床试验/NCT04919850
NCT04919850已完成不适用

Effect of 60-days Saccharomyces Boulardii and Superoxide Dismutase Supplementation on Body Composition, Hunger Sensation, Pro/Antioxidant Ratio, Inflammation and Hormonal Lipo-metabolic Biomarkers in Obese Adults: a Double-blind, Placebo-controlled Trial

Azienda di Servizi alla Persona di Pavia2 个研究点 分布在 1 个国家目标入组 25 人开始时间: 2018年1月15日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
25
试验地点
2
主要终点
Change on state of hunger, fullness, desire to eat, satiety and prospective food consumption

研究概览

简要总结

In animals it has been demonstrated that Saccharomyces boulardii decrease low-grade inflammation and fat mass; also Superoxide Dismutase (SOD) decrease low-grade inflammation. Therefore, the aim of this double-blind, placebo-controlled clinical trial was to assess the effect of a 60-days S. boulardii and SOD supplementation on circulating markers of inflammation, body composition, hunger sensation, pro/antioxidant ratio, hormonal, lipid profile, glucose, insulin and HOMA-IR, in obese adults (BMI 30-35 kg/m2).

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double (Participant, Investigator)

入排标准

年龄范围
30 Years 至 65 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • I class of obesity (BMI: 30-35 Kg/m2)

排除标准

  • evidence of heart, kidney or liver disease
  • diagnosis of major depressive disorder
  • current medications for weight loss, for control of cholesterol and triglycerides
  • anti-inflammatory treatments
  • pregrancy of lactation
  • type 1 diabetes mellitus, intestinal inflammatory bowel disease, celiac disease, chronic pancreatitis
  • probiotic/prebiotic treatment in the last 4 weeks
  • antibiotic use within the last 3 months

结局指标

主要结局

Change on state of hunger, fullness, desire to eat, satiety and prospective food consumption

时间窗: Changes from baseline state of hunger, fullness, desire to eat, satiety and prospective food consumption at 8 weeks

Eating motivation Visual Analogue Scale (pt): a scale from 0 to 10 points. The scale of hunger (question: "how hungry are you?") ranged from the answer "not at all" to "as hungry as I have ever felt"; the scale of fullness (question: "how full are you?") ranged from the answer "not at all" to "as full as I ever felt"; the scale of satiety (question: "how satiated are you?") ranged from "not at all" to "extremely"; the scale of desire (question: "how strong is your desire to eat?") ranged from "very weak" to "very strong"; the scale of prospective consumption (question: "how much do you think you could (or would want to) eat right now) ranged from "nothing at all" to "a very large amount"

Change on concentration of biochemical parameters for hunger sensation and hormonal status

时间窗: Changes from baseline biochemical parameters for hunger sensation and hormonal status at 8 weeks

Ghrelin (pg/mL), Adiponectin (pg/ml), Peptide YY (pg/ml)

Change on concentration of biochemical parameters for glico-metabolic status

时间窗: Changes from baseline biochemical parameters for glico-metabolic status at 8 weeks

Total cholesterol (mg/dL), Low Density Lipoprotein cholesterol (mg/dL), HDL cholesterol (mg/dL), Triglycerides (mg/dL), Apolipoprotein A (mg/dL), Apolipoprotein B (mg/dL), Glycemia (mg/dL), Uric acid (mg/dL)

次要结局

  • Change on concentration of biochemical parameters for hormonal status(Changes from baseline biochemical parameters for hormonal status at 8 weeks)
  • Change on status of mood assessment(Changes from baseline mood assessment at 8 weeks)
  • Change on status of assessment of food preferences(Changes from baseline assessment of food preferences at 8 weeks)
  • Change on concentration of biochemical parameters for nutritional status(Changes from baseline biochemical parameters for nutritional status at 8 weeks)
  • Change on concentration of biochemical parameters for inflammation and cardiovascular risk(Changes from baseline biochemical parameters for inflammation and cardiovascular risk at 8 weeks)
  • Change on concentration of biochemical parameters for safety(Changes from baseline biochemical parameters for safety at 8 weeks)
  • Change on rate of anthropometric measures(Changes from baseline anthropometric measures at 8 weeks)
  • Change on rate of body composition(Changes from baseline body composition at 8 weeks)

研究者

发起方
Azienda di Servizi alla Persona di Pavia
申办方类型
Other
责任方
Principal Investigator
主要研究者

Mariangela Rondanelli

Professor

Azienda di Servizi alla Persona di Pavia

研究点 (2)

Loading locations...

相似试验